13989 completed, 2987 unknown, 1751 recruiting, 1123 terminated. 9227 Not applicable, 2338 Phase 2, 2301 Phase 3, 2060 Phase 1, 2031 Phase 4.
Follow Diabetes Mellitus: new trials by email Literature Review of Diabetes Mellitus trials Research Report on Diabetes Mellitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance | Phase 2 | Withdrawn | University of Arizona | 2030-04-15 | 2025-07-30 | |
| MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention - Type 2 Diabetes, Medication Adherence | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 45 | 2029-05-01 | 2026-05-20 |
| Insul-In This Together: Leveraging Family Support and Diabetes Technology for Adolescents Living With Type 1 Diabetes Insul-In This Together - Diabetes Type 1 | Not applicable | Not yet recruiting | Stanford University | 200 | 2028-01-01 | 2026-10-05 |
| Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome | Phase 2 / Phase 3 | Not yet recruiting | University of Massachusetts, Worcester | 226 | 2027-09-01 | 2026-09-28 |
| GLP-1 RA for Stage 1 Type 1 Diabetes Semaglutide, Placebo - Stage 1 Diabetes Mellitus, Type 1 | Phase 2 | Not yet recruiting | Children's Hospital Medical Center, Cincinnati | 15 | 2027-09-01 | 2026-02-24 |
| South Asians With Type 2 Diabetes at Risk for Depression CHW-led T2D Intervention - Type 2 Diabetes | Not applicable | Not yet recruiting | NYU Langone Health | 100 | 2027-08-01 | 2026-05-19 |
| cfMSC Therapy for Diabetes cfMSC therapy for diabetes - Type II Diabetes Mellitus | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-08-27 |
| On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery 12-week exercise regimen, 12-week standard of care - Diabetic Foot Ulcer | Not applicable | Not yet recruiting | University of Maryland, Baltimore | 60 | 2027-06-01 | 2026-10-07 |
| Na-Phenylbutyrate VAscular Trial Sodium Phenylbutyrate, Placebo - Diabetes | Early Phase 1 | Not yet recruiting | University of Pennsylvania | 30 | 2027-06-01 | 2026-07-28 |
| The Prevalence of Hyperglycemia in Surgical Patients With Pre-diabetes Prediabetes or Diabetes, Surgery Complications | Not yet recruiting | University of Calgary | 750 | 2027-05-01 | 2026-06-23 | |
| Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation HEARTS implementation strategies, Supply chain strengthening - Hypertension (HTN), Type 2 Diabetes | Not applicable | Not yet recruiting | University of Michigan | 1440 | 2027-05-01 | 2026-04-17 |
| Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D) ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30) | Not applicable | Not yet recruiting | Boston Scientific Corporation | 50 | 2027-04-01 | 2026-09-24 |
| Eye Health Intervention Study in Upper Manhattan Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy | Not applicable | Withdrawn | Columbia University | 2027-04-01 | 2026-05-29 | |
| Mindful Eating and Mindful Movement for Persons With Type 2 Diabetes Mellitus Standard of Care Diet and Exercise Group, Mindful Eating and Mindful Movement (MEMO) Group - Type 2 Diabetes | Not applicable | Not yet recruiting | Northeastern University | 60 | 2027-03-01 | 2026-09-18 |
| Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study Integrated Digital Health (IDH) platform, Provider engagement - Diabetes, Diabetes Type 2 | Not applicable | Not yet recruiting | Yale University | 300 | 2027-03-01 | 2026-09-29 |
| Testing a Diabetes Care Program in Rural and Low-Income Clinics Community Health Worker-led diabetes program - Type 2 Diabetes Mellitus | Not applicable | Not yet recruiting | The University of Texas Medical Branch, Galveston | 200 | 2027-03-01 | 2026-08-14 |
| Continuous Glucose Monitoring for In-hospital Management of Type 2 Diabetes Continuous glucose monitoring - Diabetes, Continuous Glucose Monitoring System | Not applicable | Not yet recruiting | Steno Diabetes Center Copenhagen | 314 | 2027-03-01 | 2026-09-01 |
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Tracking Income Dynamics and Everyday Health Study Preventative health review invitation early in SNAP cycle, Financial counseling invitation early in the SNAP cycle, Aim 3 follow-up call early in the SNAP period - HIV, Hypertension | Not applicable | Not yet recruiting | University of Pennsylvania | 400 | 2027-03-01 | 2026-10-19 |
| Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2 PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION, Sham percutaneous electrical nerve field stimulation - Diabetes, Gastroparesis | Not applicable | Not yet recruiting | Indiana University | 60 | 2027-02-10 | 2026-10-01 |
Showing 20 of 22170. Sign in to see all of them.
Diabetes Mellitus, Type 2 (9999) · Diabetes Mellitus, Type 1 (3564) · Obesity (1870) · Insulin Resistance (1187) · Hypertension (1110) · Diabetic Foot (1030) · Prediabetic State (911) · Diabetes, Gestational (829) · Cardiovascular Diseases (753) · Diabetic Retinopathy (682) · Motor Activity (638) · Overweight (541) · Diabetic Neuropathies (522) · Diabetic Nephropathies (514)
Endocrine System Diseases (22044) · Nutritional and Metabolic Diseases (20205) · Metabolic Diseases (19992) · Glucose Metabolism Disorders (19954) · Pathological Conditions, Signs and Symptoms (4254) · Immune System Diseases (3772) · Autoimmune Diseases (3572) · Vascular Diseases (3558) · Cardiovascular Diseases (3550) · Signs and Symptoms (2945) · Diabetes Complications (2721) · Body Weight (2146) · Urogenital Diseases (2144) · Nutrition Disorders (2116)
Metformin (897) · Insulin Glargine (523) · Sitagliptin Phosphate (392) · Insulin (359) · Insulin Aspart (316) · Exercise (314) · dapagliflozin (298) · semaglutide (293) · Liraglutide (268) · Pioglitazone (248) · empagliflozin (248) · Standard of Care (225) · Insulin Lispro (207) · Continuous Glucose Monitoring (195) · Insulin Detemir (192)
Novo Nordisk A/S (849) · AstraZeneca (381) · Eli Lilly and Company (324) · Sanofi (270) · Merck Sharp & Dohme LLC (196) · GlaxoSmithKline (155) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (149) · Boehringer Ingelheim (147) · University of Colorado, Denver (127) · Takeda (124) · Pfizer (114) · University of Aarhus (108) · Brigham and Women's Hospital (99) · Assiut University (98) · Emory University (95)
United States (7612) · China (1468) · Canada (1419) · Germany (1341) · United Kingdom (1165) · France (953) · Denmark (890) · Italy (799) · Spain (775) · South Korea (748) · Turkey (Türkiye) (658) · Mexico (596) · Netherlands (541) · India (529) · Brazil (515)
PMID 38770818, PMID 39963952, PMID 38682786, PMID 33166419, PMID 22236356, PMID 25387217, PMID 25504028, PMID 35472672, PMID 31903692, PMID 32998732, PMID 32501595, PMID 39171639, PMID 35044568, PMID 22913891, PMID 31606880, PMID 33107592, PMID 34213819, PMID 23010561, PMID 26894924, PMID 32267058, PMID 39735417, PMID 26580237, PMID 27402391, PMID 35224730, PMID 36542287, PMID 37435938, PMID 24517339, PMID 32306296, PMID 32803882, PMID 33210751, PMID 33327727, PMID 41805697, PMID 21450987, PMID 21883806, PMID 22193143, PMID 22234149, PMID 22862847, PMID 23130654, PMID 23186975, PMID 24170235, PMID 24786834, PMID 26232910, PMID 27977934, PMID 30615985, PMID 30880443, PMID 31769496, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382
2009 (81), 2015 (74), 2014 (69), 2017 (64), 2019 (61), 2008 (60), 2016 (56), 2018 (56), 2023 (48), 2025 (46), 2005 (34), 2004 (11), OT2HL158287 (10), P30DK111024 (9), P50MD017338 (7)